Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_918b468caec358dab39547707dd26553 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6884 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2019-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b90dfba191d5e8bd518aa1eb5190920c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7adc4ec42d505d8f69dc479bc7e831c3 |
publicationDate |
2021-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-112240935-A |
titleOfInvention |
Application of OPN protein expressed in urine of lung cancer patients |
abstract |
The invention provides a method for detecting urine protein, and successfully detects the expression of Osteopontin 1 (OPN) in the urine of normal people and lung cancer patients. The invention confirms the expression characteristics of OPN in the urine of normal people and lung cancer patients through research, and confirms that it has diagnostic value for the disease conditions of the patients. |
priorityDate |
2019-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |